Biohal is a decentralized preventive medicine platform that extensively uses liquid biopsy authentication protocol to detect Cancer and Alzheimer’s at early stages. Biohal’s mission is to create a universally available preventive medicine platform that runs on blockchain with liquid biopsy protocol. By joining hands with PROTEO, the first liquid biopsy research partner, Biohal can detect cancer and alzheimer’s at early stages. With minimally invasive markers, Biohal’s test accuracy remains at 99%.
Disclosure:This page is created to provide market intelligence. This is not investment advice and does not constitute any solicitation or endorsement of any investment. Any investment you make is done at your own risk and at your full and absolute discretion.
